Skandinaviska Enskilda Banken (SEB)
BSX icon

Skandinaviska Enskilda Banken (SEB)’s Boston Scientific BSX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.3M Sell
387,252
-2,447,803
-86% -$196M 0.56% 21
2025
Q4 		$270M Buy
2,835,055
+280,373
+11% +$27.5M 1.08% 13
2025
Q3 		$249M Buy
2,554,682
+529,529
+26% +$54.8M 1% 15
2025
Q2 		$218M Buy
2,025,153
+663,569
+49% +$67.1M 0.95% 16
2025
Q1 		$137M Buy
1,361,584
+420,824
+45% +$42.4M 0.68% 26
2024
Q4 		$84.4M Sell
940,760
-4,631
-0.5% -$408K 0.38% 45
2024
Q3 		$79.2M Buy
945,391
+13,713
+1% +$1.08M 0.37% 51
2024
Q2 		$71.7M Sell
931,678
-185,963
-17% -$13.6M 0.34% 55
2024
Q1 		$76.5M Sell
1,117,641
-20,059
-2% -$1.29M 0.37% 47
2023
Q4 		$65.8M Buy
1,137,700
+59,492
+6% +$3.18M 0.38% 48
2023
Q3 		$56.9M Sell
1,078,208
-6,611
-0.6% -$347K 0.37% 52
2023
Q2 		$58.7M Buy
1,084,819
+19,875
+2% +$1.04M 0.38% 55
2023
Q1 		$53.3M Sell
1,064,944
-63,790
-6% -$3.01M 0.37% 55
2022
Q4 		$52.2M Buy
1,128,734
+61,948
+6% +$2.68M 0.39% 59
2022
Q3 		$41.3M Sell
1,066,786
-22,658
-2% -$909K 0.32% 74
2022
Q2 		$40.6M Buy
1,089,444
+165,455
+18% +$6.74M 0.3% 73
2022
Q1 		$40.9M Buy
923,989
+596,952
+183% +$25.9M 0.24% 88
2021
Q4 		$14.1M Sell
327,037
-1,398,991
-81% -$58.8M 0.07% 232
2021
Q3 		$74.9M Buy
1,726,028
+1,359,727
+371% +$60.2M 0.41% 55
2021
Q2 		$15.7M Buy
366,301
+25,361
+7% +$1.07M 0.1% 209
2021
Q1 		$13.2M Buy
340,940
+3,495
+1% +$132K 0.09% 224
2020
Q4 		$12.1M Sell
337,445
-1,076
-0.3% -$38.8K 0.08% 213
2020
Q3 		$12.9M Buy
338,521
+50,165
+17% +$1.93M 0.09% 197
2020
Q2 		$10.1M Sell
288,356
-32,222
-10% -$1.16M 0.08% 226
2020
Q1 		$10.5M Buy
320,578
+15,235
+5% +$595K 0.11% 178
2019
Q4 		$13.8M Buy
305,343
+37,243
+14% +$1.56M 0.11% 177
2019
Q3 		$10.9M Sell
268,100
-548
-0.2% -$23.2K 0.09% 205
2019
Q2 		$11.5M Buy
268,648
+16,999
+7% +$654K 0.1% 188
2019
Q1 		$9.66M Buy
251,649
+900
+0.4% +$34.4K 0.09% 190
2018
Q4 		$8.86M Buy
250,749
+17,632
+8% +$639K 0.08% 189
2018
Q3 		$8.97M Sell
233,117
-9,300
-4% -$325K 0.07% 204
2018
Q2 		$7.93M Buy
242,417
+75,276
+45% +$2.27M 0.07% 209
2018
Q1 		$4.57M Sell
167,141
-76,763
-31% -$2.09M 0.04% 238
2017
Q4 		$6.05M Buy
243,904
+3,463
+1% +$95.5K 0.05% 257
2017
Q3 		$7.01M Buy
240,441
+12,400
+5% +$342K 0.06% 236
2017
Q2 		$6.32M Buy
228,041
+3,100
+1% +$82.3K 0.06% 261
2017
Q1 		$5.59M Sell
224,941
-2,965
-1% -$72.1K 0.06% 264
2016
Q4 		$4.93M Sell
227,906
-10,067
-4% -$220K 0.06% 238
2016
Q3 		$5.66M Buy
237,973
+19,700
+9% +$470K 0.06% 227
2016
Q2 		$5.1M Sell
218,273
-13,500
-6% -$292K 0.06% 244
2016
Q1 		$4.36M Sell
231,773
-14,800
-6% -$260K 0.05% 265
2015
Q4 		$4.55M Buy
+246,573
New +$4.42M 0.06% 228

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s BSX Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) reduced its Boston Scientific (BSX) stake by 86% in Q1 2026, selling an estimated $196M and leaving 387,252 shares worth $24.3M. The position accounts for 0.56% of the portfolio, ranked #21.

Skandinaviska Enskilda Banken (SEB) first reported a position in BSX in Q4 2015 and has held it in 42 quarters since. The position peaked at $270M in Q4 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) held 387,252 shares of Boston Scientific worth $24.3M as of Q1 2026.
  • Skandinaviska Enskilda Banken (SEB) sold 2,447,803 Boston Scientific shares in Q1 2026, an estimated $196M.
  • Boston Scientific made up 0.56% of Skandinaviska Enskilda Banken (SEB)'s portfolio in Q1 2026, its #21 holding.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Boston Scientific in Q4 2015 and has held it in 42 quarters since.
  • Skandinaviska Enskilda Banken (SEB)'s Boston Scientific position peaked at $270M in Q4 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.